- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Opioids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Opioids size is estimated to be xx million in 2021 from USD 15210 million in 2020, with a change of XX% between 2020 and 2021. The global Opioids market size is expected to grow at a CAGR of 2.5% for the next five years.
Market segmentation
Opioids market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
Market segment by Application can be divided into
Pain Relief
Anesthesia
Cough Suppression
Diarrhea Suppression
Deaddiction
Others
The key market players for global Opioids market are listed below:
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Opioids product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioids, with price, sales, revenue and global market share of Opioids from 2019 to 2021.
Chapter 3, the Opioids competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Opioids market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Opioids sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Opioids Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Opioids Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Opioids Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Cough Suppression
1.3.5 Diarrhea Suppression
1.3.6 Deaddiction
1.3.7 Others
1.4 Global Opioids Market Size & Forecast
1.4.1 Global Opioids Sales in Value (2016-2026))
1.4.2 Global Opioids Sales in Volume (2016-2026)
1.4.3 Global Opioids Price by Type (2016-2026) & (USD/Kg)
1.5 Global Opioids Production Capacity Analysis
1.5.1 Global Opioids Total Production Capacity (2016-2026)
1.5.2 Global Opioids Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Opioids Market Drivers
1.6.2 Opioids Market Restraints
1.6.3 Opioids Trends Analysis
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Opioids Product and Services
2.1.4 Teva Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Purdue Pharma
2.2.1 Purdue Pharma Details
2.2.2 Purdue Pharma Major Business
2.2.3 Purdue Pharma Opioids Product and Services
2.2.4 Purdue Pharma Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Opioids Product and Services
2.3.4 Mallinckrodt Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Amneal Pharma
2.4.1 Amneal Pharma Details
2.4.2 Amneal Pharma Major Business
2.4.3 Amneal Pharma Opioids Product and Services
2.4.4 Amneal Pharma Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Collegium
2.5.1 Collegium Details
2.5.2 Collegium Major Business
2.5.3 Collegium Opioids Product and Services
2.5.4 Collegium Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 J&J
2.6.1 J&J Details
2.6.2 J&J Major Business
2.6.3 J&J Opioids Product and Services
2.6.4 J&J Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Endo
2.7.1 Endo Details
2.7.2 Endo Major Business
2.7.3 Endo Opioids Product and Services
2.7.4 Endo Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Opioids Product and Services
2.8.4 Pfizer Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 INSYS
2.9.1 INSYS Details
2.9.2 INSYS Major Business
2.9.3 INSYS Opioids Product and Services
2.9.4 INSYS Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Opioids Product and Services
2.10.4 Mylan Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Hikma
2.11.1 Hikma Details
2.11.2 Hikma Major Business
2.11.3 Hikma Opioids Product and Services
2.11.4 Hikma Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Egalet
2.12.1 Egalet Details
2.12.2 Egalet Major Business
2.12.3 Egalet Opioids Product and Services
2.12.4 Egalet Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Opioids Sales by Manufacturer
3.1 Global Opioids Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Opioids Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Opioids
3.4 Market Concentration Rate
3.4.1 Top 3 Opioids Manufacturer Market Share
3.4.2 Top 6 Opioids Manufacturer Market Share
3.5 Global Opioids Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Opioids Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Opioids Market Size by Region
4.1.1 Global Opioids Sales in Volume by Region (2016-2026)
4.1.2 Global Opioids Revenue by Region (2016-2026)
4.2 North America Opioids Revenue (2016-2026)
4.3 Europe Opioids Revenue (2016-2026)
4.4 Asia-Pacific Opioids Revenue (2016-2026)
4.5 South America Opioids Revenue (2016-2026)
4.6 Middle East and Africa Opioids Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Opioids Sales in Volume by Type (2016-2026)
5.2 Global Opioids Revenue by Type (2016-2026)
5.3 Global Opioids Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Opioids Sales in Volume by Application (2016-2026)
6.2 Global Opioids Revenue by Application (2016-2026)
6.3 Global Opioids Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Opioids Sales by Type (2016-2026)
7.2 North America Opioids Sales by Application (2016-2026)
7.3 North America Opioids Market Size by Country
7.3.1 North America Opioids Sales in Volume by Country (2016-2026)
7.3.2 North America Opioids Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Opioids Sales by Type (2016-2026)
8.2 Europe Opioids Sales by Application (2016-2026)
8.3 Europe Opioids Market Size by Country
8.3.1 Europe Opioids Sales in Volume by Country (2016-2026)
8.3.2 Europe Opioids Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Opioids Sales by Type (2016-2026)
9.2 Asia-Pacific Opioids Sales by Application (2016-2026)
9.3 Asia-Pacific Opioids Market Size by Region
9.3.1 Asia-Pacific Opioids Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Opioids Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Opioids Sales by Type (2016-2026)
10.2 South America Opioids Sales by Application (2016-2026)
10.3 South America Opioids Market Size by Country
10.3.1 South America Opioids Sales in Volume by Country (2016-2026)
10.3.2 South America Opioids Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Opioids Sales by Type (2016-2026)
11.2 Middle East & Africa Opioids Sales by Application (2016-2026)
11.3 Middle East & Africa Opioids Market Size by Country
11.3.1 Middle East & Africa Opioids Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Opioids Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Opioids Typical Distributors
12.3 Opioids Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Opioids Revenue by Type, (USD Million), 2021-2026
Table 2. Global Opioids Revenue by Application, (USD Million), 2021-2026
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Opioids Product and Services
Table 6. Teva Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Purdue Pharma Major Business
Table 9. Purdue Pharma Opioids Product and Services
Table 10. Purdue Pharma Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 12. Mallinckrodt Major Business
Table 13. Mallinckrodt Opioids Product and Services
Table 14. Mallinckrodt Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Amneal Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Amneal Pharma Major Business
Table 17. Amneal Pharma Opioids Product and Services
Table 18. Amneal Pharma Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Collegium Basic Information, Manufacturing Base and Competitors
Table 20. Collegium Major Business
Table 21. Collegium Opioids Product and Services
Table 22. Collegium Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. J&J Basic Information, Manufacturing Base and Competitors
Table 24. J&J Major Business
Table 25. J&J Opioids Product and Services
Table 26. J&J Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Endo Basic Information, Manufacturing Base and Competitors
Table 28. Endo Major Business
Table 29. Endo Opioids Product and Services
Table 30. Endo Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Major Business
Table 33. Pfizer Opioids Product and Services
Table 34. Pfizer Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. INSYS Basic Information, Manufacturing Base and Competitors
Table 36. INSYS Major Business
Table 37. INSYS Opioids Product and Services
Table 38. INSYS Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Mylan Basic Information, Manufacturing Base and Competitors
Table 40. Mylan Major Business
Table 41. Mylan Opioids Product and Services
Table 42. Mylan Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Hikma Basic Information, Manufacturing Base and Competitors
Table 44. Hikma Major Business
Table 45. Hikma Opioids Product and Services
Table 46. Hikma Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Egalet Basic Information, Manufacturing Base and Competitors
Table 48. Egalet Major Business
Table 49. Egalet Opioids Product and Services
Table 50. Egalet Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Opioids Sales by Manufacturer (2019-2021e) & (MT)
Table 52. Global Opioids Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Opioids, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Opioids Production Capacity by Company, (MT): 2020 VS 2021
Table 55. Head Office and Opioids Production Site of Key Manufacturer
Table 56. Opioids New Entrant and Capacity Expansion Plans
Table 57. Opioids Mergers & Acquisitions in the Past Five Years
Table 58. Global Opioids Sales by Region (2016-2021e) & (MT)
Table 59. Global Opioids Sales by Region (2021-2026) & (MT)
Table 60. Global Opioids Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global Opioids Revenue by Region (2021-2026) & (USD Million)
Table 62. Global Opioids Sales by Type (2016-2021e) & (MT)
Table 63. Global Opioids Sales by Type (2021-2026) & (MT)
Table 64. Global Opioids Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global Opioids Revenue by Type (2021-2026) & (USD Million)
Table 66. Global Opioids Price by Type (2016-2021e) & (USD/Kg)
Table 67. Global Opioids Price by Type (2021-2026) & (USD/Kg)
Table 68. Global Opioids Sales by Application (2016-2021e) & (MT)
Table 69. Global Opioids Sales by Application (2021-2026) & (MT)
Table 70. Global Opioids Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global Opioids Revenue by Application (2021-2026) & (USD Million)
Table 72. Global Opioids Price by Application (2016-2021e) & (USD/Kg)
Table 73. Global Opioids Price by Application (2021-2026) & (USD/Kg)
Table 74. North America Opioids Sales by Country (2016-2021e) & (MT)
Table 75. North America Opioids Sales by Country (2021-2026) & (MT)
Table 76. North America Opioids Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America Opioids Revenue by Country (2021-2026) & (USD Million)
Table 78. North America Opioids Sales by Type (2016-2021e) & (MT)
Table 79. North America Opioids Sales by Type (2021-2026) & (MT)
Table 80. North America Opioids Sales by Application (2016-2021e) & (MT)
Table 81. North America Opioids Sales by Application (2021-2026) & (MT)
Table 82. Europe Opioids Sales by Country (2016-2021e) & (MT)
Table 83. Europe Opioids Sales by Country (2021-2026) & (MT)
Table 84. Europe Opioids Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe Opioids Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe Opioids Sales by Type (2016-2021e) & (MT)
Table 87. Europe Opioids Sales by Type (2021-2026) & (MT)
Table 88. Europe Opioids Sales by Application (2016-2021e) & (MT)
Table 89. Europe Opioids Sales by Application (2021-2026) & (MT)
Table 90. Asia-Pacific Opioids Sales by Region (2016-2021e) & (MT)
Table 91. Asia-Pacific Opioids Sales by Region (2021-2026) & (MT)
Table 92. Asia-Pacific Opioids Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific Opioids Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific Opioids Sales by Type (2016-2021e) & (MT)
Table 95. Asia-Pacific Opioids Sales by Type (2021-2026) & (MT)
Table 96. Asia-Pacific Opioids Sales by Application (2016-2021e) & (MT)
Table 97. Asia-Pacific Opioids Sales by Application (2021-2026) & (MT)
Table 98. South America Opioids Sales by Country (2016-2021e) & (MT)
Table 99. South America Opioids Sales by Country (2021-2026) & (MT)
Table 100. South America Opioids Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America Opioids Revenue by Country (2021-2026) & (USD Million)
Table 102. South America Opioids Sales by Type (2016-2021e) & (MT)
Table 103. South America Opioids Sales by Type (2021-2026) & (MT)
Table 104. South America Opioids Sales by Application (2016-2021e) & (MT)
Table 105. South America Opioids Sales by Application (2021-2026) & (MT)
Table 106. Middle East & Africa Opioids Sales by Country (2016-2021e) & (MT)
Table 107. Middle East & Africa Opioids Sales by Country (2021-2026) & (MT)
Table 108. Middle East & Africa Opioids Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa Opioids Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Opioids Sales by Type (2016-2021e) & (MT)
Table 111. Middle East & Africa Opioids Sales by Type (2021-2026) & (MT)
Table 112. Middle East & Africa Opioids Sales by Application (2016-2021e) & (MT)
Table 113. Middle East & Africa Opioids Sales by Application (2021-2026) & (MT)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Opioids Typical Distributors
Table 117. Opioids Typical Customers
List of Figures
Figure 1. Opioids Picture
Figure 2. Global Opioids Sales Market Share by Type in 2020
Figure 3. Oxycodone
Figure 4. Hydromorphone
Figure 5. Codeine
Figure 6. Fentanyl
Figure 7. Other
Figure 8. Global Opioids Sales Market Share by Application in 2020
Figure 9. Pain Relief
Figure 10. Anesthesia
Figure 11. Cough Suppression
Figure 12. Diarrhea Suppression
Figure 13. Deaddiction
Figure 14. Others
Figure 15. Global Opioids Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 16. Global Opioids Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. Global Opioids Sales (2016-2026) & (MT)
Figure 18. Global Opioids Price by Type (2016-2026) & (USD/Kg)
Figure 19. Global Opioids Production Capacity (2016-2026) & (MT)
Figure 20. Global Opioids Production Capacity by Geographic Region: 2020 VS 2021
Figure 21. Opioids Market Drivers
Figure 22. Opioids Market Restraints
Figure 23. Opioids Market Trends
Figure 24. Global Opioids Sales Market Share by Manufacturer in 2020
Figure 25. Global Opioids Revenue Market Share by Manufacturer in 2020
Figure 26. Opioids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. Top 3 Opioids Manufacturer (Revenue) Market Share in 2020
Figure 28. Top 6 Opioids Manufacturer (Revenue) Market Share in 2020
Figure 29. Global Opioids Sales Market Share by Region (2016-2026)
Figure 30. Global Opioids Revenue Market Share by Region (2016-2026)
Figure 31. North America Opioids Revenue (2016-2026) & (USD Million)
Figure 32. Europe Opioids Revenue (2016-2026) & (USD Million)
Figure 33. Asia-Pacific Opioids Revenue (2016-2026) & (USD Million)
Figure 34. South America Opioids Revenue (2016-2026) & (USD Million)
Figure 35. Middle East & Africa Opioids Revenue (2016-2026) & (USD Million)
Figure 36. Global Opioids Sales Market Share by Type (2016-2026)
Figure 37. Global Opioids Revenue Market Share by Type (2016-2026)
Figure 38. Global Opioids Price by Type (2016-2026) & (USD/Kg)
Figure 39. Global Opioids Sales Market Share by Application (2016-2026)
Figure 40. Global Opioids Revenue Market Share by Application (2016-2026)
Figure 41. Global Opioids Price by Application (2016-2026) & (USD/Kg)
Figure 42. North America Opioids Sales Market Share by Type (2016-2026)
Figure 43. North America Opioids Sales Market Share by Application (2016-2026)
Figure 44. North America Opioids Sales Market Share by Country (2016-2026)
Figure 45. North America Opioids Revenue Market Share by Country (2016-2026)
Figure 46. United States Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Opioids Sales Market Share by Type (2016-2026)
Figure 50. Europe Opioids Sales Market Share by Application (2016-2026)
Figure 51. Europe Opioids Sales Market Share by Country (2016-2026)
Figure 52. Europe Opioids Revenue Market Share by Country (2016-2026)
Figure 53. Germany Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Opioids Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Opioids Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Opioids Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Opioids Revenue Market Share by Region (2016-2026)
Figure 62. China Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Korea Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Opioids Sales Market Share by Type (2016-2026)
Figure 69. South America Opioids Sales Market Share by Application (2016-2026)
Figure 70. South America Opioids Sales Market Share by Country (2016-2026)
Figure 71. South America Opioids Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East & Africa Opioids Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Opioids Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Opioids Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Opioids Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Egypt Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South Africa Opioids Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
